LATEST TWEETS - CURATED BY HASH FINANCE

Big3Bio:SFBay (Big3BioSF) 36 minutes ago
In order to develop #ClinicalTrials, #Verily has formed collaborations with Pfizer, Sanofi, Novartis, and Otsuka.… https://t.co/rlO6UoieQ5
Pfizer Posts Positive Phase 3 Study In Eczema, Catalysts Remain In Second Half Of 2019 https://t.co/VVsPy0KnD0 $PFE https://t.co/NopE4HhXpX
Recommendation #HOLD for $SNY with UB rating - 3.19 out of 5. https://t.co/OB736LsJAg
Trade4Me (trade4me_net) 17 hours ago
$SNY Breakout Mode, V Shape, Above 50 DMA, Above Average Volume, Dividend 2.84%, BOP-Positive, Entry: $ 42.20 , Tar… https://t.co/Fl2euCbfFc
Alphabet’s Verily has partnered with @Novartis, @Sanofi, @OtsukaUS and @Pfizer in an effort to modernize… https://t.co/iCWwCMWbWK
Regeneron's $REGN stock bounced off the trendline support and is heading back up to test the 326.13 level. Sanofi… https://t.co/59gHs5gC6W
Johnson & Johnson has been ordered to pay $25 million in another talc lawsuit and more for #pharma #marketers to kn… https://t.co/iGtwquamGD
Campbell & Company Investment Adviser Holds Holding in Ttm Technologies $TTMI; Corda Investment Management Holding… https://t.co/akgql14f5T
Pharmalot.. Pharmalittle.. Good Morning.. Lawmakers push bill to punish opioid execs, Novartis has 'enormous levera… https://t.co/tWTFWyaZHF
News for #pharma #marketers to know: Wed, May 22 -Verily partners with pharma companies on #clinicaltrials - $JNJ l… https://t.co/19yiejp5ty
$SNY Phase 3 trial w/est May completion date NCT01957436: https://t.co/vvmRhiEKby Trial Tracker: https://t.co/aR7q5oJwjn
@bobjherman @_jacquie_lee Shareholder value trumps patient care. The founders of insulin refused to profit from the… https://t.co/mlaYZFd2WV
Verily and large #pharma form a strategic alliance to modernize clinical trials and accelerate drug development.… https://t.co/Fr1tY7XurL
$SNY Phase 3 trial w/est May completion date NCT02926937: https://t.co/M5FclmXeHI Trial Tracker: https://t.co/aR7q5oJwjn
$MDCO “twice annual dosing” is still not possible at least during the first year, since it is actually 3 injections… https://t.co/I8sqrjLE4X
Sanofi $SNY Holder Greenleaf Trust Has Lifted Position; Capital Investment Advisors Has Decreased Its Procter & Gam… https://t.co/2iWQ7IKfXY
@_B_I_O_T_E_C_H_ So now we know that one of $SGMO's undisclosed targets in in #gaucher disease. I think this will g… https://t.co/Hd5FtN2c56
@J_O_Connell Yep, that’s why -as a last resort- they will write you an Rx for #Repatha now...& -if u have good insu… https://t.co/r86VwE3ftP
Updated: SELLAS Life Sciences Group $SLS In Acquisition Discussions With Janssen Oncology As Johnson & Johnson $JNJ https://t.co/9NsP4a3ZTy
Pharma Giant #Sanofi Expanding into Digital Health Solutions https://t.co/vGxqS3be0y via @mydocwire $SNY
Pharma Giant Sanofi Expanding into #DigitalHealth Solutions https://t.co/vGxqS3be0y via @mydocwire $SNY @sanofi… https://t.co/83mMB7Kq5o
$SNY Phase 3 trial w/est May completion date NCT03066830: https://t.co/W1sSrnh6vs Trial Tracker: https://t.co/aR7q5oJwjn
Explore #fundamental numbers and pros and cons for $SNY https://t.co/QeuJrttUi8
We calculated 21-day Expected Return of $SNY for you: 6.28% https://t.co/S6LvUsIEEQ
Wondering about risks of $SNY? The 63-day volatility is 7.94% https://t.co/eK4c26exWe
Recommendation #HOLD for $SNY with UB rating - 3.19 out of 5. https://t.co/OB736LsJAg